BlackRock Group’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $243M | Sell |
|
|||||
|
2016
Q3 | $249M | Sell |
|
|||||
|
2016
Q2 | $238M | Sell |
|
|||||
|
2016
Q1 | $285M | Sell |
|
|||||
|
2015
Q4 | $464M | Sell |
|
|||||
|
2015
Q3 | $383M | Buy |
|
|||||
|
2015
Q2 | $423M | Buy |
|
|||||
|
2015
Q1 | $365M | Sell |
|
|||||
|
2014
Q4 | $394M | Buy |
|
|||||
|
2014
Q3 | $329M | Buy |
|
|||||
|
2014
Q2 | $306M | Buy |
|
|||||
|
2014
Q1 | $281M | Buy |
|
|||||
|
2013
Q4 | $197M | Buy |
|
|||||
|
2013
Q3 | $166M | Sell |
|
|||||
|
2013
Q2 | $132M | Buy |
|